Piacenza, Italy

Giovannia Caponetti


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 152(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Giovannia Caponetti: Innovator in Pulmonary Drug Delivery

Introduction

Giovannia Caponetti is a notable inventor based in Piacenza, Italy. She has made significant contributions to the field of pulmonary drug delivery, focusing on the development of aerodynamically light particles. With a total of 2 patents, her work is paving the way for advancements in medical treatments.

Latest Patents

Caponetti's latest patents include innovative methods for creating aerodynamically light particles designed for pulmonary drug delivery. These particles are made from biodegradable materials and possess a tap density of less than 0.4 g/cm, with a mass mean diameter ranging between 5 µm and 30 µm. The particles can be formed from functionalized polyester graft copolymers, which consist of a linear α-hydroxy-acid polyester backbone. This backbone incorporates amino acid groups and poly(amino acid) side chains, enhancing the particles' effectiveness in delivering therapeutic or diagnostic agents to the alveolar region of the lung. The particles can be aerosolized for administration to the respiratory tract, allowing for systemic or local delivery of a variety of incorporated agents.

Career Highlights

Throughout her career, Giovannia Caponetti has worked with prestigious institutions, including the Massachusetts Institute of Technology. Her research and innovations have garnered attention in the scientific community, contributing to the advancement of drug delivery systems.

Collaborations

Caponetti has collaborated with notable individuals in her field, including David A. Edwards and Jeffrey S. Hrkach. These partnerships have further enhanced her research and development efforts in pulmonary drug delivery.

Conclusion

Giovannia Caponetti is a pioneering inventor whose work in aerodynamically light particles for pulmonary drug delivery is making a significant impact in the medical field. Her innovative approaches and collaborations are setting new standards for effective drug administration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…